Very early anthropometric changes after antiretroviral therapy predict subsequent survival, in Karonga, Malawi

Open AIDS Journal

Volumn 6, Issue 1, 2012, Pages 36-44

  Maman, David ^a,b,c,d,e   Glynn, Judith R ^f   Crampin, Amelia C ^f   Kranzer, Katharina ^f   Saul, Jacqueline ^f   Jahn, Andreas ^f   Mwinuka, Venance ^g   Ngwira, Msenga H C ^h   Mvula, Hazzie ^g   Munthali, Fipson ^h   McGrath, Nuala ^f,i  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^e EPICENTRE   (France)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g KARONGA PREVENTION STUDY   (Malawi)

^h Karonga District Hospital   (Malawi)

ⁱ UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Anthropometric measure; Antiretroviral therapy; HIV; Mortality; Sub Saharan Africa

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

ADOLESCENT; ADULT; ARM CIRCUMFERENCE; ARTICLE; BODY HEIGHT; BODY MASS; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; DRUG EFFECT; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALAWI; MALE; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RURAL AREA; SURVIVAL RATE; TREATMENT DURATION;

EID: 84861895851     PISSN: None     EISSN: 18746136     Source Type: Journal    
DOI: 10.2174/1874613601206010036     Document Type: Article

References (17)

1. Glynn JR, Ponnighaus J, Crampin AC, et al. The development of the HIV epidemic in Karonga District, Malawi. AIDS 2001; 15(15): 2025-2029.
2. UNAIDS. Report on the Global AIDS Epidemic. Geneva: UNAIDS 2008.
3. Treatment of AIDS: The 2 year plan to scale up antiretroviral therapy in Malawi. Ministry of Health and population, Malawi; 2004 February 2004.
4. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006; 367(9519): 1335-1342.
5. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18(6): 887-895.
6. Toure S, Kouadio B, Seyler C, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS 2008; 22(7): 873-882.
7. Bussmann H, Wester CW, Ndwapi N, et al. Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program. AIDS 2008; 22(17): 2303-2311.
8. Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health 2009; 14(1): 36-43.
9. Zachariah R, Fitzgerald M, Massaquoi M, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006; 20(18): 2355-2360.
10. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 2006; 296(7): 782-793.
11. Messou E, Gabillard D, Moh R, et al. Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults. Bull World Health Organ 2008; 86(6): 435-442.
12. Madec Y, Szumilin E, Genevier C, et al. Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries. AIDS 2009; 27(7): 853-861.
13. Koethe JR, Lukusa A, Giganti MJ, et al. Association between weight gain and clinical outcomes among malnourished adults initiating antiretroviral therapy in Lusaka, Zambia. J Acquir Immune Defic Syndr 2010; 53(4): 507-513.
14. Gustafson P, Gomes VF, Vieira CS, et al. Clinical predictors for death in HIV-positive and HIV-negative tuberculosis patients in Guinea-Bissau. Infection 2007; 35(2): 69-80.
15. McGrath N, Glynn JR, Saul J, et al. What happens to ART-eligible patients who do not start ART? Dropout between screening and ART initiation: a cohort study in Karonga, Malawi. BMC Public Health 2010; 10: 601.
16. James WP, Ferro-Luzzi A, Waterlow JC. Definition of chronic energy deficiency in adults. Report of a working party of the International Dietary Energy Consultative Group. Eur J Clin Nutr 1988; 42(12): 969-981.
17. WHO. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Geneva 1995.